Saxenda (Liraglutide) Weight Loss Injection Pen – 6 mg/mL

Saxenda (Liraglutide) Weight Loss Injection Pen (6 mg/mL) is a prescription-based glucagon-like peptide-1 (GLP-1) receptor agonist used for chronic weight management in adults with obesity or overweight conditions with weight-related comorbidities. It is designed to help regulate appetite, increase satiety, and reduce overall caloric intake as part of a medically supervised weight management program.

Saxenda contains liraglutide, a synthetic analogue of the human incretin hormone GLP-1. It works by acting on appetite centers in the brain and slowing gastric emptying, which helps patients feel fuller for longer and reduces hunger between meals. It is intended to be used alongside a reduced-calorie diet and increased physical activity.

Key Component

Liraglutide (6 mg/mL)

Liraglutide is a GLP-1 receptor agonist that mimics the action of naturally occurring incretin hormones involved in glucose regulation and appetite control.

Mechanism-related effects include:

• Reduces appetite and food intake
• Increases satiety after meals
• Slows gastric emptying
• Helps regulate energy balance
• Supports gradual weight reduction when combined with lifestyle changes

Product Benefits

• Medically supported weight management
• Reduction of body weight in obese or overweight patients
• Appetite and hunger control
• Improved eating behavior regulation
• Supports long-term weight maintenance strategies
• Can be used alongside diet and exercise programs

Treatment Areas / Indications

• Chronic weight management in adults with obesity
• Overweight patients with weight-related comorbidities (e.g., hypertension, dyslipidemia)
• Appetite regulation support in medically supervised programs

Technology

Saxenda uses recombinant DNA technology to produce liraglutide, a long-acting GLP-1 receptor agonist with extended activity in the body. Its formulation allows once-daily subcutaneous administration and sustained receptor activation, supporting consistent appetite regulation and metabolic effects.

Dosage & Administration

Package Contents: Pre-filled injection pen

Concentration: 6 mg/mL liraglutide

• For prescription use only under medical supervision.
• Administered via subcutaneous injection once daily.
• Dose is typically increased gradually according to clinical protocol.
• Used alongside diet and exercise program.
• Not intended for cosmetic or non-medical use.

The exact dosing schedule and treatment duration must always be determined by a qualified healthcare professional.